| Dr Matthew Alan Cunningham-hill, MD | |
|
1 Medical Center Dr, Morgantown, WV 26506-1200 | |
| (855) 988-2273 | |
| Not Available |
| Full Name | Dr Matthew Alan Cunningham-hill |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1 Medical Center Dr, Morgantown, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275997348 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MT211017 (Pennsylvania) | Secondary |
| 208600000X | Surgery | 30387 (West Virginia) | Primary |
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
The National Nanotechnology Initiative (NNI) today published the report from the workshop, "Stakeholder Perspectives on Perception, Assessment, and Management of the Potential Risks of Nanotechnology" (R3 Workshop), which was held September 10-11, 2013, in Washington, D.C.
Make room, cholesterol. A new disease marker is entering the medical lexicon: suPAR, or soluble urokinase-type plasminogen activator receptor.
With lawmakers trying to reach a compromise to avert a government shutdown and set the federal government's spending for the rest of the year, funding for the health law could face challenges in the House and the Senate.
› Verified 7 days ago
| Entity Name | Wheeling Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104821305 PECOS PAC ID: 5799689493 Enrollment ID: O20031124000706 |
News Archive
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
The National Nanotechnology Initiative (NNI) today published the report from the workshop, "Stakeholder Perspectives on Perception, Assessment, and Management of the Potential Risks of Nanotechnology" (R3 Workshop), which was held September 10-11, 2013, in Washington, D.C.
Make room, cholesterol. A new disease marker is entering the medical lexicon: suPAR, or soluble urokinase-type plasminogen activator receptor.
With lawmakers trying to reach a compromise to avert a government shutdown and set the federal government's spending for the rest of the year, funding for the health law could face challenges in the House and the Senate.
› Verified 7 days ago
| Entity Name | St Joseph's Hospital Of Buckhannon Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124005061 PECOS PAC ID: 6709828163 Enrollment ID: O20050525000839 |
News Archive
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
The National Nanotechnology Initiative (NNI) today published the report from the workshop, "Stakeholder Perspectives on Perception, Assessment, and Management of the Potential Risks of Nanotechnology" (R3 Workshop), which was held September 10-11, 2013, in Washington, D.C.
Make room, cholesterol. A new disease marker is entering the medical lexicon: suPAR, or soluble urokinase-type plasminogen activator receptor.
With lawmakers trying to reach a compromise to avert a government shutdown and set the federal government's spending for the rest of the year, funding for the health law could face challenges in the House and the Senate.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Alan Cunningham-hill, MD 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: (855) 988-2273 | Dr Matthew Alan Cunningham-hill, MD 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: (855) 988-2273 |
News Archive
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
The National Nanotechnology Initiative (NNI) today published the report from the workshop, "Stakeholder Perspectives on Perception, Assessment, and Management of the Potential Risks of Nanotechnology" (R3 Workshop), which was held September 10-11, 2013, in Washington, D.C.
Make room, cholesterol. A new disease marker is entering the medical lexicon: suPAR, or soluble urokinase-type plasminogen activator receptor.
With lawmakers trying to reach a compromise to avert a government shutdown and set the federal government's spending for the rest of the year, funding for the health law could face challenges in the House and the Senate.
› Verified 7 days ago
Dr. Matthew Craig Cindric, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 J D Anderson Dr, Morgantown, WV 26505 Phone: 304-598-1996 Fax: 304-285-2107 | |
Dr. Frank Cantrell Griswold, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 Wedgewood Dr, Suite 202, Morgantown, WV 26505 Phone: 304-599-1905 Fax: 304-599-5335 | |
David Randall Hofius, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3000 Mon Health Medical Park Dr Ste 3300, Morgantown, WV 26505 Phone: 304-599-1448 Fax: 304-599-5335 | |
Jerome Gordon Johnson, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1000 Mon Health Medical Park Dr, Suite 1100, Morgantown, WV 26505 Phone: 304-599-1448 Fax: 304-599-5335 | |
Dr. Majed Youssef Maalouf, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 | |
Dr. Alison Wilson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800 | |
Dr. Ehab A Akkary, MD Surgery Medicare: Medicare Enrolled Practice Location: 1100 Fort Pierpont Dr Ste 101, Morgantown, WV 26508 Phone: 304-241-1100 Fax: 304-983-8800 |